Inactive Instrument

Diaxonhit Stock Euronext Paris

Equities

FR0004054427

Biotechnology & Medical Research

Financials

Sales 2023 * 131M 140M 191M Sales 2024 * 138M 148M 202M Capitalization 146M 156M 214M
Net income 2023 * 6M 6.43M 8.78M Net income 2024 * 9M 9.64M 13.17M EV / Sales 2023 * 1.19 x
Net Debt 2023 * 8.8M 9.43M 12.87M Net cash position 2024 * 9.9M 10.61M 14.48M EV / Sales 2024 * 0.99 x
P/E ratio 2023 *
33.2 x
P/E ratio 2024 *
15 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 59.14%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 17-06-18
Director of Finance/CFO 43 22-09-30
Chief Operating Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - 17-06-18
Director/Board Member 68 09-11-03
Director/Board Member 67 17-06-14
More insiders
Eurobio Scientific is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The group has approximately 286 employees, three production units based in the Paris region, in Germany and in the United States, and subsidiaries in Dorking in the United Kingdom, Sissach in Switzerland, Bünde in Germany and Utrecht in the Netherlands.
Calendar
More about the company